Not Tagged
Not Tagged
['mmsm']
another ctc super abstract at #ash22 by and colleagues. reproducible 0.01% cutoff for risk stratification at diagnosis, and value of mrd-ctc monitoring after treatment regardless of serological response. is ctc the new mrd in myeloma? #mmsm 
Director Flow Cytometry Core - CIMA LAB Diagnostics
Director Myeloma Laboratory - Clinica & CIMA Universidad de Navarra